Glioma-associated endothelial cells are chemoresistant to temozolomide (Q44633285)

4 December 2017

title

Glioma-associated endothelial cells are chemoresistant to temozolomide (English)

1 reference

4 December 2017

0 references

0 references

3

Walavan Sivakumar

1 reference

4 December 2017

Jenilyn J Virrey

1

1 reference

4 December 2017

Encouse B Golden

2

1 reference

4 December 2017

Weijun Wang

4

1 reference

4 December 2017

Ligaya Pen

5

1 reference

4 December 2017

Axel H Schönthal

6

1 reference

4 December 2017

Florence M Hofman

7

1 reference

4 December 2017

Thomas C Chen

8

1 reference

4 December 2017

publication date

18 April 2009

1 reference

Journal of Neuro-Oncology

4 December 2017

published in

1 reference

4 December 2017

volume

95

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

13-22

1 reference

New trends in the medical management of glioblastoma multiforme: the role of temozolomide chemotherapy.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Changing paradigms--an update on the multidisciplinary management of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Temozolomide: realizing the promise and potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Functional and phenotypic differences between glioblastoma multiforme-derived and normal human brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Transient down-regulation of beta1 integrin subtypes on kidney carcinoma cells is induced by mechanical contact with endothelial cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Increased survivin expression confers chemoresistance to tumor-associated endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Glioma-associated endothelial cells show evidence of replicative senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Interleukin-8 differentially regulates migration of tumor-associated and normal human brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Antiangiogenic strategies on defense: on the possibility of blocking rebounds by the tumor vasculature after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Angiogenesis of glioma: evaluation of ultrastructural characteristics of microvessels and tubular bodies (Weibel-Palade) in endothelial cells and immunohistochemical findings with VEGF and p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Combination of antiangiogenesis with chemotherapy for more effective cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9891-7

Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.

21 January 2018

1 reference

12 December 2020

Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecan

1 reference

12 December 2020

Temozolomide and thalidomide in the treatment of glioblastoma multiforme.

1 reference

12 December 2020

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

1 reference

12 December 2020

Combination celecoxib and temozolomide in C6 rat glioma orthotopic model.

1 reference

12 December 2020

Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.

1 reference

12 December 2020

Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea.

1 reference

12 December 2020

Interleukin‐8 secreted by endothelial cells induces Chemotaxis of melanoma cells through the chemokine receptor CXCR1

1 reference

12 December 2020

10.1007/S11060-009-9891-7

Identifiers

DOI

1 reference

4 December 2017

1 reference